Genomics Market
Genomics Market Size, Share & Trends Analysis Report by Deliverable (Product, and Services), by Technology (Sequencing, PCR, Nucleic Acid Extraction and Purification, Microarray, and Other) by Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal Research, and Other), and by End-User (Hospitals & Clinics, Academic and Research Centers, Pharmaceutical & Biotechnology Companies, and Other), Forecast Period (2022-2028)
Genomics market is anticipated to grow at a significant CAGR of 15.3% during the forecast period. The key factors contributing to the market growth include, the glove governments in several countries are doing and made investments/funding in the field of genomics. For instance, in April 2021, UK Government made an investment of $4.2 billion for genomics projects and data-driven initiatives which are to be delivered through the Genome UK Implementation Plan and the UK Functional Genomics Initiative. This funding is made to transform the UK into a life sciences superpower and is supporting medicines and vaccine development. Thus attributed to such government investments, funding is playing a key impacting factor in the development of new technologies, and that further increases the market growth.
Segmental Outlook
The global genomics market is segmented based on the deliverable, technology, application, and end-user. On the basis of type, the market is segmented into products and services. Based on the technology, the market is segmented into sequencing, PCR, nucleic acid extraction and purification, microarray, and others. Based on the application, the market is subdivided into drug discovery and development, diagnostics, agriculture and animal research, and others. Based on the end-user, the market is subdivided into hospitals & clinics, academic and research centers, pharmaceutical & biotechnology companies, and others. Among end-user segments pharmaceutical & biotechnology companies segments are estimated to hold a prominent share in the market due to the growing number of genetic research studies, increasing number of drug discoveries, and increasing new players' entrance into genomics services to meet the increasing demand by the end-user market. For instance, in June 2020, Illumina, Inc., has acquired Bluebee to analyze and interpret the data produced by its sequencing systems. The new capabilities by BlueBee company lower the cost of storing, sharing, and managing the enormous volumes of genomic data for a base of more than 15,000 sequencing systems.
Among the application segment, the drug discoveries segment is anticipated to dominate in the market owing to the growing research on diseases including cancer and genetic disorders, increasing technological developments, and new drug discoveries technique implemented are such factors that are contributing to the segmental growth. For instance, in July 2021, Eli Lilly and Verge Genomics entered into a partnership to research and create new drugs for the treatment of amyotrophic lateral sclerosis (ALS). With this new partnership Verge is developed an all-in-human, artificial-intelligence (AI)-driven drug discovery and development platform to develop treatments for serious genetic diseases. This new platform is being used to advance them into clinical trials and markets. Moreover, increasing several research by pharmaceuticals, laboratories, and others, and the decreasing cost of sequencing is such other factors driving the market growth.
Regional Outlooks
The global genomics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East &Africa, and Latin America. North America region is estimated to hold a prominent share owing to well-established healthcare infrastructure, and ley players such as Qiagen, Roche Diagnostic, and Illumina, Inc., among others operating in the region are driving market growth further in the region.
Global Genomics Market Growth, by Region 2022-2028
The Asia-Pacific Region is Fastest Growing in the Global Genomics Market
The region is estimated to witness the fastest growth in the market owing to increasing drug discoveries, growing several research programs and funding, and increasing supportive government by the approvals, funding, and grants are such key factors that drive regional market growth. For instance, in September 2020, the Department of Biotechnology (DBT) introduced a new project "Genome India Project" (GIP) that aims to collect 10,000 genetic samples from citizens across India and build a reference genome. This new project is led by the Centre for Brain Research at the Bengaluru-based Indian Institute of Science and is specially designed for applications such as Precision health, Rare genetic disorders, and the Mutation spectrum of genetic and complex diseases among others. In addition in September 2021, the Indian government decided to involve private sector laboratories in the process of genome sequencing for the detection of COVID-19 by that it can scale up genomic surveillance in the country.
Market Players Outlook
The major companies serving the global genomics market include Agilent Technologies, Inc., Danaher Corp., Eurofins Scientific Ltd., F. Hoffmann-La Roche Ltd., Illumina Inc., Quest Diagnostics, Thermo Fisher Scientific, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in February 2022, Tesis Biosciences acquired Genome Explorations to accelerate clinical research and product development to expedite the completion of a therapeutic clinical initiative. This new acquisition in the development of proprietary products for transforming how chronic diseases are treated. Enabling clinicians to individualize treatment for people with cancer and other chronic diseases, improves the quality of life of Americans and revolutionizes medicine.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global genomics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Danaher Corp.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Eurofins Scientific Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Illumina Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Quest Diagnostics
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Thermo Fisher Scientific
3.6.1. Overview
3.6.2. Financial Analysis
3.6.3. SWOT Analysis
3.6.4. Recent Developments
3.7. Key Strategy Analysis
4. Market Segmentation
4.1. Global Genomics Market By Deliverable
4.1.1. Product
4.1.2. Services
4.2. Global Genomics Market By Technology
4.2.1. Sequencing
4.2.2. PCR
4.2.3. Nucleic Acid Extraction and Purification
4.2.4. Microarray
4.2.5. Other
4.3. Global Genomics Market By Application
4.3.1. Drug Discovery and Development
4.3.2. Diagnostics
4.3.3. Agriculture and Animal Research
4.3.4. Other
4.4. Global Genomics Market By End-User
4.4.1. Hospitals & Clinics
4.4.2. Academic and Research Centers
4.4.3. Pharmaceutical & Biotechnology Companies
4.4.4. Other (Clinical Research)
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 23andMe
6.2. Agilent Technologies, Inc.
6.3. BEX CO.,LTD.
6.4. Bio-Rad Laboratories, Inc.
6.5. BGI
6.6. Color Health, Inc.
6.7. DEEP GENOMICS
6.8. DNA and U
6.9. Eppendorf SE
6.10. F. Hoffmann-La Roche Ltd.
6.11. General Electric Co.
6.12. GenScript Biotech Corp.
6.13. IntegraGen SA
6.14. Intellia Therapeutics, Inc.
6.15. Invitae Corp.Myriad Genetics, Inc.
6.16. Oxford Nanopore Technologies
6.17. Pacific Biosciences,
6.18. Parexel International Corp
6.19. QIAGEN GmbH
6.20. Verge Analytics, Inc.
6.21. VERITAS INTERCONTINENTAL
1. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERABLE, 2021-2028 ($ MILLION)
2. GLOBAL GENOMICS PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL GENOMICS SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
5. GLOBAL GENOMICS SEQUENCING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL GENOMICS PCR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL GENOMICS NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL GENOMICS MICROARRAY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GENOMICS OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. GLOBAL GENOMICS DRUG DISCOVERY AND DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL GENOMICS DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL GENOMICS AGRICULTURE AND ANIMAL RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL GENOMICS OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL GENOMICS NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL GENOMICS MICROARRAY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL GENOMICS OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
19. GLOBAL GENOMICS IN HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL GENOMICS IN ACADEMIC AND RESEARCH CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. GLOBAL GENOMICS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22. GLOBAL GENOMICS IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
23. GLOBAL GENOMICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
24. NORTH AMERICAN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. NORTH AMERICAN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERABLE, 2021-2028 ($ MILLION)
26. NORTH AMERICAN GENOMICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
27. NORTH AMERICAN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
28. NORTH AMERICAN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
29. EUROPEAN GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
30. EUROPEAN GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERABLE, 2021-2028 ($ MILLION)
31. EUROPEAN GENOMICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
32. EUROPEAN GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
33. EUROPEAN GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
34. ASIA-PACIFIC GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
35. ASIA-PACIFIC GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERABLE, 2021-2028 ($ MILLION)
36. ASIA-PACIFIC GENOMICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
37. ASIA-PACIFIC GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
38. ASIA-PACIFIC GENOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
39. REST OF THE WORLD GENOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
40. REST OF THE WORLD GENOMICS MARKET RESEARCH AND ANALYSIS BY DELIVERABLE, 2021-2028 ($ MILLION)
41. REST OF THE WORLD GENOMICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
42. REST OF THE WORLD GENOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
43. REST OF THE WORLD GENOMICS MARKET RESEARCH AND ANALYSIS BY SERVICES, 2021-2028 ($ MILLION)?
1. GLOBAL GENOMICS MARKET SHARE BY DELIVERABLE, 2021 VS 2028 (%)
2. GLOBAL GENOMICS PRODUCT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
3. GLOBAL GENOMICS SERVICES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
4. GLOBAL GENOMICS MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
5. GLOBAL GENOMICS SEQUENCING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL GENOMICS PCR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL GENOMICS NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL GENOMICS MICROARRAY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL GENOMICS OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL GENOMICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL GENOMICS DRUG DISCOVERY AND DEVELOPMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL GENOMICS DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL GENOMICS AGRICULTURE AND ANIMAL RESEARCH MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL GENOMICS OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL GENOMICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
16. GLOBAL GENOMICS IN HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL GENOMICS IN ACADEMIC AND RESEARCH CENTERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL GENOMICS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL GENOMICS IN OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. GLOBAL GENOMICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21. US GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
22. CANADA GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
23. UK GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
24. FRANCE GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
25. GERMANY GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
26. ITALY GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
27. SPAIN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF EUROPE GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
29. INDIA GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
30. CHINA GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
31. JAPAN GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
32. SOUTH KOREA GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF ASIA-PACIFIC GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
34. REST OF THE WORLD GENOMICS MARKET SIZE, 2021-2028 ($ MILLION)
